NT 10-Q

EXTENSION

Company: Sonoma Pharmaceuticals, Inc.
Filed: November 14, 2013
Period of Report: September 30, 2013
Accession Number: 0001019687-13-004356

View Document ↗ View on SEC.gov ↗